| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INTRACELLULAR SIGNAL SYSTEMS |
,
,
) in
T3-1 and LßT2 Gonadotrope Cell Lines
Centre National de la Recherche Scientifique UMR 6544, Université de la Méditerranée, Faculté de Médecine, 13916 Marseille, France
Address all correspondence and requests for reprints to: S. V. Drouva, Interactions Cellulaires Neuroendocrieniennes, UMR 6544 Centre National de la Recherche Scientifique, IFR Jean-Roche, Fac Med Nord, Bd P. Dramard, 13916 Marseille Cedex 20, France. E-mail: . drouva.sv{at}jean-roche.univ-mrs.fr
We investigated mechanisms underlying selective down-modulation of PKC isoforms (
,
,
): 1) during 12-O-tetradecanoyl-phorbol-13 acetate (TPA) (10-7 M) or GnRH (10-7 M) desensitization conditions (2- to 6-h treatments) in two gonadotrope cell lines (
T3-1, LßT2) and 2) in primary pituitary cell cultures from male rats during long-term phorbol ester administration. We demonstrated that, as in
T3-1 cells, in a more differentiated gonadotrope cell line LßT2 the GnRH-receptor coupling (PLC, PLA2, PLD) generated second messengers essential for PKCs activation; the characterized isoforms (
, ßII,
,
,
) were selectively and differentially down-regulated by TPA (
, ßII,
,
) or GnRH (
,
). In whole cell lysates, proteasome inhibitors (proteasome inhibitor I and II, Lactacystin, ß-Lactone, Calpain inhibitor I) prevented in both gonadotrope cell lines the TPA-induced depletion of PKC
,
, and the GnRH-elicited PKC
down-regulation; they counteracted in mixed pituitary cell cultures as well, the TPA-evoked PKC
,
depletion. In contrast, the inhibitors of calpain(s) and lysosomal proteases (Calpeptin, E64d, Calpain inhibitor II, and PD150606), were ineffective. As shown in
T3-1 subcellular fractions, proteasome abrogation did not affect membrane translocation of TPA- and GnRH- target isoforms (
,
) but, preventing their degradation, favored enzyme accumulation to the membrane compartment. Proteolysis processing of PKCs may be dependent upon their phosphorylated state and/or catalytic activity. Inhibition of PKC catalytic activity (GF109203X, Gö6976), selectively prevented the TPA-evoked PKC
depletion in both mixed pituitary cells and
T3-1 gonadotropes; in
T3-1 subcellular fractions, PKC
inactivation overcame the TPA-evoked isoenzyme degradation by inducing a pronounced membrane accumulation of the isoform without affecting its membrane relocalization. Thus, the proteasome system by adjusting PKC cellular levels, may represent a regulatory proteolytic pathway implicated in the adaptive mechanisms of the time dependent cell responses.
This article has been cited by other articles:
![]() |
D. Chen, C. Gould, R. Garza, T. Gao, R. Y. Hampton, and A. C. Newton Amplitude Control of Protein Kinase C by RINCK, a Novel E3 Ubiquitin Ligase J. Biol. Chem., November 16, 2007; 282(46): 33776 - 33787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lariviere, G. Garrel, V. Simon, J.-W. Soh, J.-N. Laverriere, R. Counis, and J. Cohen-Tannoudji Gonadotropin-Releasing Hormone Couples to 3',5'-Cyclic Adenosine-5'-Monophosphate Pathway through Novel Protein Kinase C{delta} and -{epsilon} in L{beta}T2 Gonadotrope Cells Endocrinology, March 1, 2007; 148(3): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. M. Urban, M. L. Cayer, H. K. Plummer III, and C. A. Heckman Actin-based features negatively regulated by protein kinase C-{epsilon} Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1002 - C1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, M. S. Ruiz, D. A. Austin, and N. J. G. Webster Constitutively Active Gq Impairs Gonadotropin-Releasing Hormone-Induced Intracellular Signaling and Luteinizing Hormone Secretion in L{beta}T2 Cells Mol. Endocrinol., August 1, 2005; 19(8): 2074 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Peiretti, M. Canault, D. Bernot, B. Bonardo, P. Deprez-Beauclair, I. Juhan-Vague, and G. Nalbone Proteasome inhibition activates the transport and the ectodomain shedding of TNF-{alpha} receptors in human endothelial cells J. Cell Sci., March 1, 2005; 118(5): 1061 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al. Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kedei, D. J. Lundberg, A. Toth, P. Welburn, S. H. Garfield, and P. M. Blumberg Characterization of the Interaction of Ingenol 3-Angelate with Protein Kinase C Cancer Res., May 1, 2004; 64(9): 3243 - 3255. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Leontieva and J. D. Black Identification of Two Distinct Pathways of Protein Kinase C{alpha} Down-regulation in Intestinal Epithelial Cells J. Biol. Chem., February 13, 2004; 279(7): 5788 - 5801. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liu, D. A. Austin, and N. J. G. Webster Gonadotropin-Releasing Hormone-Desensitized L{beta}T2 Gonadotrope Cells Are Refractory to Acute Protein Kinase C, Cyclic AMP, and Calcium-Dependent Signaling Endocrinology, October 1, 2003; 144(10): 4354 - 4365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |